Zoeken
Solide tumoren, CLDN1+, fase 1, ALE.P02 ADC
Solide tumoren, CLDN1+, fase 1, ALE.P03
Solide tumoren, HER2-mutatie/amplificatie, fase 1 populatie, zongertinib
Solide tumoren, HER2 positief, fase 1, click-cleavable beeldvorming
Niet-kleincellig longcarcinoom, MET mutatie, fase 1, MET kinase inhibitor
Hepatocellulair carcinoom, fase 1, holmium-166
Solide tumoren, fase 1, CD137/PD-L1 bispecifiek antilichaam
mCRPC, fase 1/2, GSK5471713
Solide tumoren, fase 1 populatie, patritumab deruxtecan
Solide tumoren, fase 1, infinatamab deruxtexan
mCRPC, fase 1, ifinatamab deruxtecan
Solide tumoren, fase 1, T-cell engager, anti-nectine-4
Solide tumoren, fase 1, BI 3810944
mCRPC, fase 1, Lu-PSMA-617
PDAC, G12V KRAS mutatie, fase 1, TCR-T celtherapie
